Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Feb. 29, 2020
Feb. 28, 2019
Statement of Operations [Abstract]    
Net revenue $ 148,580 $ 11,107
Cost of goods sold (182,779) (5,549)
Gross (loss) profit (34,199) 5,558
OPERATING EXPENSES    
Depreciation 6,514 9,178
Amortization of patent rights 16,218 1,833
Foreign currency transaction loss 3,955 13,533
Selling, general and administrative 1,565,831 1,097,968
TOTAL OPERATING EXPENSES 1,592,518 1,122,512
LOSS FROM OPERATIONS (1,626,717) (1,116,954)
OTHER (EXPENSE) INCOME    
Accretion of debt discounts (498,124) (102,858)
Interest expense (159,532) (59,390)
Change in fair value of derivative liabilities   395,430
LOSS BEFORE INCOME TAXES (2,284,373) (883,772)
Income tax provision 0 0
NET LOSS (2,284,373) (883,772)
Foreign exchange translation adjustment for the period (36,596) (3,740)
COMPREHENSIVE LOSS $ (2,320,969) $ (887,512)
Net loss per share - basic and diluted (in dollars per share) $ (0.02) $ (0.01)
Weighted-average number of common shares outstanding during the period (in shares) 104,659,194 102,435,923